Introduction {#sec1}
============

Heart failure (HF) is a leading cause of 30-day all-cause readmission, a metric used in the U.S. healthcare system to reduce readmission to lower Medicare costs \[[@cit0001], [@cit0002]\]. Few transitional care interventions have been shown to be consistently associated with a lower risk of 30-day all-cause readmission in HF \[[@cit0003]--[@cit0005]\]. While some of the evidence-based HF drugs are effective in lowering the risk of 30-day all-cause readmission \[[@cit0006]--[@cit0012]\], none are effective in HF patients with preserved ejection fraction (HFpEF), who constitute over half of all older HF patients \[[@cit0013]\]. We have previously demonstrated that a discharge hospice referral is associated with a lower risk of 30-day all-cause readmission in patients with HF regardless of EF \[[@cit0014]\]. However, less is known about the association between home health care and 30-day all-cause readmission in HF \[[@cit0015], [@cit0016]\]. In the current analysis we examined the association between discharge home health referral and 30-day all-cause readmission in a propensity score-matched balanced cohort of HF patients.

Material and methods {#sec2}
====================

Data source and study patients {#sec2.1}
------------------------------

The Alabama HF Project is a Medicare quality improvement project, the details of which have been previously described \[[@cit0008], [@cit0017], [@cit0018]\]. Briefly, medical records of 9649 fee-for-service Medicare beneficiaries who had a principal discharge diagnosis of HF based on International Classification of Diseases 9 codes were abstracted by trained abstractors. These patients were admitted for acute HF to 106 Alabama hospitals between July 1, 1998 and October 31, 2001. The 9649 hospitalizations occurred in 8555 unique patients, of whom 8049 were discharged alive. We restricted our analysis to the 6406 patients who were not admitted from nursing homes, who were discharged home, and who did not receive a discharge hospice referral. Of these, 1369 (21%) patients received a discharge referral for home health services ([Figure 1](#f0001){ref-type="fig"}).

![Flow chart displaying assembly of a balanced matched cohort for hospitalized heart failure (HF) patients receiving and not receiving discharge home health care (HHC) referrals](AMS-14-33456-g001){#f0001}

Retrospective assembly of a balanced cohort {#sec2.2}
-------------------------------------------

We used a non-parsimonious logistic regression model to estimate propensity scores for home health services referral for each of the 6406 patients \[[@cit0019]--[@cit0022]\]. In the model, home health services referral was the dependent variable and 33 measured baseline characteristics displayed in [Figure 1](#f0001){ref-type="fig"} were used as covariates. The propensity score for home health referral is the conditional probability of receiving a home health referral based on these 33 baseline characteristics. We then used the propensity scores to assemble a matched cohort of 1253 pairs of patients receiving and not receiving home health referrals and examined between-group post-match balances for all 33 baseline characteristics using absolute standardized differences \[[@cit0023]\].

Outcomes data {#sec2.3}
-------------

Our primary outcome of interest was 30-day all-cause readmission. Other outcomes studied included 30-day all-cause mortality, 30-day HF readmissions, and a combined end-point of all-cause mortality or all-cause readmission at 30 days. All outcomes were examined at 12 months. Data on outcomes and time to events were obtained from Medicare claims data \[[@cit0017]\].

Statistical analyses {#sec2.4}
--------------------

Descriptive analyses included Pearson's χ^2^ and Wilcoxon rank-sum tests as appropriate. Association analysis included Cox regression models among matched patients. Kaplan-Meier survival analysis was used to generate plots for 1-year all-cause readmissions by home health services referral. Formal sensitivity analyses were performed to determine the confounding impact of a potentially unmeasured baseline characteristic on our observed outcomes \[[@cit0024]\]. We also examined the association of home health services use with the primary outcome among the 6406 pre-match patients using Cox regression models, unadjusted and separately adjusting for propensity scores and the 33 variables used to estimate propensity scores. All statistical tests were two-tailed with a *p*-value \< 0.05 considered significant. IBM SPSS Statistics for Windows, Version 23 Armonk, NY: IBM Corp. was used for data analyses.

Results {#sec3}
=======

Baseline characteristics {#sec3.1}
------------------------

The 2506 matched patients had a mean age of 78 years, 61% were women, and 27% were African American. Before matching, patients receiving referrals for home health services were generally older and more likely to be female. More patients in the home health services group had prior HF, chronic obstructive pulmonary disease (COPD), or stroke, and fewer patients received discharge prescriptions for angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs), and β-blockers ([Table I](#t0001){ref-type="table"}). These along with other imbalances were balanced in the matched cohort ([Table I](#t0001){ref-type="table"}, [Figure 2](#f0002){ref-type="fig"}).

###### 

Baseline characteristics of patients with heart failure, by home health referral, before and after propensity matching

  Parameter *n* (%) or mean ± SD           Before propensity score matching   After propensity score matching                                      
  ---------------------------------------- ---------------------------------- --------------------------------- ---------- ----------- ----------- -------
  Age \[years\]                            73 ±11                             78 ±10                            \< 0.001   78 ±9       78 ±10      0.762
  Female                                   2695 (54)                          850 (62)                          \< 0.001   766 (61)    775 (62)    0.743
  African American                         1317 (26)                          369 (27)                          0.556      332 (27)    333 (27)    1.000
  Left ventricular ejection fraction:                                                                                                              
   \< 45%                                  2070 (41)                          487 (36)                          \< 0.001   469 (37)    455 (36)    0.759
   ≥ 45%                                   1561 (31)                          364 (27)                          350 (28)   347 (28)                
   Unknown                                 1406 (28)                          518 (38)                          434 (35)   451 (36)                
  Past medical history:                                                                                                                            
   Smoking history                         685 (14)                           112 (8)                           \< 0.001   105 (8)     108 (9)     0.886
   Prior heart failure                     3511 (70)                          1071 (78)                         \< 0.001   968 (77)    971 (78)    0.924
   Hypertension                            3530 (70)                          966 (71)                          0.739      861 (69)    882 (70)    0.385
   Coronary artery disease                 2848 (57)                          738 (54)                          0.086      693 (55)    680 (54)    0.630
   Diabetes mellitus                       2169 (43)                          638 (47)                          0.020      583 (47)    575 (46)    0.779
   Stroke                                  807 (16)                           365 (27)                          \< 0.001   315 (25)    305 (24)    0.677
   Chronic obstructive pulmonary disease   1763 (35)                          540 (39)                          0.003      471 (38)    490 (39)    0.460
   Dementia                                197 (4)                            138 (10)                          \< 0.001   113 (9)     110 (9)     0.888
   Cancer                                  101 (2)                            26 (2)                            0.913      24 (2)      23 (2)      1.000
   Atrial fibrillation                     1213 (24)                          413 (30)                          \< 0.001   367 (29)    367 (29)    1.000
   Left bundle branch block                708 (14)                           169 (12)                          0.110      154 (12)    157 (13)    0.904
  Clinical and laboratory findings:                                                                                                                
   Pulse \[beats/minute\]                  89 ±22                             89 ±22                            0.950      90 ±22      90 ±23      0.793
   Systolic blood pressure \[mm Hg\]       151 ±32                            146 ±33                           \< 0.001   148 ±31     147 ±33     0.718
   Pulmonary edema by chest X-ray          3261 (65)                          962 (70)                          \< 0.001   905 (72)    872 (70)    0.159
   Serum creatinine \[mEq/l\]              1.6 ±1.4                           1.5 ±1.0                          0.094      1.58 ±1.0   1.55 ±1.0   0.526
  In-hospital events:                                                                                                                              
   Pneumonia                               1047 (21)                          411 (30)                          \< 0.001   367 (29)    350 (28)    0.479
   Acute myocardial infarction             186 (4)                            56 (4)                            0.473      62 (5)      52 (4)      0.388
   Pressure ulcer                          152 (3)                            185 (14)                          \< 0.001   110 (9)     123 (10)    0.409
  Hospital and care characteristics:                                                                                                               
   Rural hospital                          1426 (28)                          526 (38)                          \< 0.001   464 (37)    474 (38)    0.710
   Cardiology care                         2817 (56)                          623 (46)                          \< 0.001   575 (46)    582 (46)    0.810
   Intensive care                          140 (3)                            65 (5)                            \< 0.001   50 (4)      49 (4)      1.000
   Length of stay                          5.6 ±3.3                           7.9 ±6.1                          \< 0.001   7.2 ±4.5    7.2 ±4.0    0.762
  Discharge medications:                                                                                                                           
   ACE inhibitors or ARB                   3209 (64)                          771 (56)                          \< 0.001   723 (58)    716 (57)    0.808
   β-Blockers                              1716 (34)                          356 (26)                          \< 0.001   331 (26)    336 (27)    0.857
   Loop diuretics                          4165 (83)                          1158 (85)                         0.104      1062 (85)   1064 (85)   0.956
   Digoxin                                 2148 (43)                          619 (45)                          0.091      560 (45)    562 (45)    0.968
   Potassium-sparing diuretics             732 (15)                           217 (16)                          0.230      207 (17)    198 (16)    0.664
   Potassium supplements                   2265 (47)                          683 (50)                          0.055      620 (50)    626 (50)    0.842
   Opioids                                 201 (4)                            79 (6)                            0.006      65 (5)      66 (5)      1.000

ACE -- angiotensin converting enzyme, ARB -- angiotensin receptor blocker.

![Love plot displaying absolute standardized differences for 33 baseline characteristics between patients receiving and not receiving home health care referrals, before and after propensity score matching\
ACE -- angiotensin converting enzyme, ARB -- angiotensin receptor blocker, COPD -- chronic obstructive lung disease, EF -- ejection fraction.](AMS-14-33456-g002){#f0002}

Associations with 30-day outcomes {#sec3.2}
---------------------------------

Among matched patients, 30-day all-cause readmission occurred in 28% and 19% of matched patients receiving and not receiving home health services referrals, respectively (hazard ratio (HR) = 1.52; 95% confidence interval (CI): 1.29--1.80; [Table II](#t0002){ref-type="table"}). Among pre-match patients, unadjusted, propensity score-adjusted, and multivariable-adjusted HRs for 30-day all-cause readmission associated with home health referrals were 1.59 (1.42--1.80), 1.46 (1.28--1.67), and 1.45 (1.27--1.65), respectively. Associations of home health referral with other 30-day outcomes are displayed in [Table II](#t0002){ref-type="table"}.

###### 

Discharge home health referral and outcomes in propensity score-matched cohort of patients with heart failure

  Variable                                        Discharge home health referral   Hazard ratios (95% confidence intervals) *P*-value   
  ----------------------------------------------- -------------------------------- ---------------------------------------------------- ---------------------------------
  30-day outcomes:                                                                                                                      
   All-cause readmission                          19% (240)                        28% (346)                                            1.52 (1.29--1.80); *p* \< 0.001
   Heart failure readmission                      9% (110)                         11% (137)                                            1.28 (0.99--1.64); *p* = 0.056
   All-cause mortality                            3% (37)                          7% (84)                                              2.32 (1.58--3.41); *p* \< 0.001
   All-cause readmission or all-cause mortality   21% (257)                        31% (387)                                            1.59 (1.36--1.86); *p* \< 0.001
  12-month outcomes:                                                                                                                    
   All-cause readmission                          69% (866)                        73% (914)                                            1.24 (1.13--1.36); *p* \< 0.001
   Heart failure readmission                      36% (449)                        36% (450)                                            1.09 (0.95--1.24); *p* = 0.216
   All-cause mortality                            30% (376)                        38% (478)                                            1.37 (1.20--1.57); *p* \< 0.001
   All-cause readmission or all-cause mortality   88% (1101)                       93% (1160)                                           1.27 (1.17--1.38); *p* \< 0.001

\*Hazard ratios comparing patients with a home health referral.

Of the 1253 matched pairs of patients receiving and not receiving a home health referral, in 509 pairs we were able to identify patients who clearly had longer readmission-free 30-day survival than their matched counterparts. In the absence of a hidden bias, a sign-score test for matched data with censoring demonstrated that in 60% (303 pairs of the 509 pairs), the home health referral group had shorter event-free survival time than their matched counterparts without a home health referral (*p* \< 0.001). A hidden covariate that is a near-perfect predictor of 30-day all-cause readmission could explain away this association if it increased the odds of home health referral by 19%.

Associations with 12-month outcomes {#sec3.3}
-----------------------------------

Twelve-month all-cause readmission occurred in 73% and 69% of matched patients receiving and not receiving home health care referrals, respectively (HR = 1.24; 95% CI: 1.13--1.36; [Table II](#t0002){ref-type="table"} and [Figure 3](#f0003){ref-type="fig"}). Home health services referral was associated with a borderline significantly higher risk of HF readmission at 1 month but not at 12 months. Associations of home health services with other 12-month outcomes are displayed in [Table II](#t0002){ref-type="table"}.

![Kaplan-Meier plots for all-cause readmission (**A**) and all-cause mortality (**B**) at 1 year by discharge home health referral (HHC) in a propensity-matched cohort of older heart failure patients (HR -- hazard ratio, CI -- confidence interval)](AMS-14-33456-g003){#f0003}

Discussion {#sec4}
==========

Findings from our current analysis demonstrate that hospitalized older patients with HF who were discharged home with home health services had a significantly higher risk of both 30-day all-cause readmission and all-cause mortality, which persisted during 12 months of follow-up. The association with 30-day HF readmission was modest and of borderline significance, and disappeared during 12-month follow-up. To the best of our knowledge, this is the first propensity score-matched study to demonstrate that Medicare beneficiaries hospitalized for HF who were discharged home with home health services, a Medicare benefit, had a higher risk of 30-day all-cause readmission, the reduction of which is a goal of the Medicare Hospital Readmission Reduction Program \[[@cit0002]\].

Patients eligible for Medicare home health services must be homebound and need intermittent skilled nursing care, both of which must be certified by a physician, who must also establish a plan of care and regularly review it. Thus, home health care services that involve intermittent skilled nursing care under supervision of a physician are unlikely to have any causal association with poor outcomes in these patients. A higher risk of mortality in patients receiving home health services is likely explained by selection or indication bias, akin to higher mortality in patients receiving insulin, where the indication bias would be diabetes \[[@cit0025]\]. Because matched patients in our study were balanced on 33 key baseline characteristics, balanced unmodifiable baseline characteristics such as age or sex are unlikely to act as confounders. However, balanced modifiable baseline characteristic such as diabetes, chronic obstructive pulmonary disease, stroke, dementia, pneumonia, and pressure ulcer may act as confounders. If these conditions were more severe or advanced in the home health group, that may in part explain the higher mortality in the home health group, as matching cannot balance disease severity or incidence of new complications during follow-up. Bias due to unmeasured or unmeasurable confounders is also possible. Finally, lower ACE inhibitor and β-blocker use in the home health group may also contribute to the higher mortality in that group \[[@cit0009], [@cit0011]\]. Although the use of these drugs was balanced after matching, if the causes of underuse at baseline (e.g., low blood pressure) continued during follow-up, then these drugs may be discontinued in more home health patients during follow-up.

Physician-supervised intermittent skilled nursing care received by home health patients is not likely to be causally associated with a higher risk of all-cause readmission, and bias by indication may explain the higher readmission in these patients. However, skilled nursing care, ironically, may also lead to a higher rate of hospital readmission due to frequent and prompt identification and reporting of the warning symptoms and signs to patients' primary care physicians, who may perceive them to be more objective than those reported by patients and/or family \[[@cit0026]\]. Unlike hospice agencies, home health care agencies do not have provisions for paid in-house medical directors, and early warning signs need to be discussed with patients' primary care physicians, which may lead to delays, worsening symptoms, and readmission \[[@cit0026]\]. Finally, the heterogeneity of care across home health teams, the lack of nursing staff specifically trained to manage HF patients, and unstructured communication during transition from hospital to home health care may also contribute \[[@cit0027], [@cit0028]\].

Interestingly, most of the 30-day all-cause readmissions associated with a home health referral was due to non-HF related causes. Of the 1253 pairs of matched patients, those in the home health group had 106 (346--240) more 30-day all-cause readmissions, but only 27 (137--110) of those were due to HF ([Table II](#t0002){ref-type="table"}). Therefore, about 75% of all 30-day all-cause readmissions were non-HF related. The association of home health referral with HF readmission is weak and likely complex. The slightly higher 30-day HF readmission in the home health group, of borderline significance, disappeared during longer follow-up. It is possible that patients were referred to home health services for reasons other than HF, such as dementia and pressure ulcer. This notion is also supported by the observation that there was no between-group difference in HF severity as indicated by similar use of digoxin and diuretics. It is possible that the incidence of worsening HF symptoms was similar in both groups, but was identified and reported at a higher rate in home health patients \[[@cit0026]\]. For example, an older HF patient may respond to worsening shortness of breath and weight gain by limiting physical activity and mobility, but may be identified by a visiting home health team. This association disappears during 1-year follow-up as the average duration of home health services is about 3 months \[[@cit0029]\].

Several studies have examined the role of home health care in readmission in HF patients. In one study that compared home health care with three home visits by a nurse versus one outpatient visit to a physician during the first post-discharge week, neither approach was found to be associated with a significant reduction in 30-day all-cause readmission \[[@cit0016]\]. However, when both approaches were combined, there was evidence of a modest reduction in the risk of readmission that was significant. Findings from two small studies suggest that programs involving home visits by nurses or pharmacists to educate or reconcile medications may have a modest association with a lower risk of 30-day all-cause readmission, but HF readmission was not reported \[[@cit0004]\]. To the best of our knowledge, this is the first report of an association of home health care with poor outcomes in a propensity score-matched cohort of HF patients.

The Veterans Health Administration (VHA) Home Based Primary Care (HBPC) program that provides comprehensive multidisciplinary services to veterans with complex health care needs has been shown to be associated with a lower readmission rate in selected veterans with medically complex diabetes mellitus \[[@cit0030]\]. Hospitalized HF patients receiving discharge hospice referral are also sick and have a higher mortality but lower readmission \[[@cit0014]\]. Hospice patients forgo aggressive medical care in favor of palliative care, which in part may explain the lower readmission rates. However, it has also been suggested that the presence of a hospice medical director and standing orders may also contribute to the lower risk of readmission. Future randomized controlled trials need to examine whether these and other strategies such as improving physical activity and mobility incorporated into the home health services program would improve outcomes, thus providing evidence of cost effectiveness of a program that often allows hospitalized frail patients to go home \[[@cit0031], [@cit0032]\].

Our study has several limitations. We had no data on patient mobility, frailty, health literacy, social support, and need for skilled nursing care for patients not receiving home health services to determine their eligibility. As mentioned above, bias from unmeasured confounders and residual bias from measured confounders are possible. We had no data on compliance, and post-discharge crossover of home health use may result in misclassification and regression dilution \[[@cit0033]\]. Our analysis is based on fee-for-service Medicare beneficiaries from a single state in an earlier era of HF management, which may limit its generalizability. Additionally, our study cannot account for changes in Medicare payment policies that affect home health utilization and services. Despite these limitations, we hope that these data highlight the need and provide incentives for randomized controlled trials that can demonstrate the beneficial effect of home health care on mortality and readmission.

In conclusion, among hospitalized older HF patients, a discharge referral for home health services was associated with higher risks for 30-day and 1-year all-cause readmission and mortality but not with HF readmission. Future studies need to replicate these intriguing findings and explain the underlying reasons for the poor outcomes among patients referred to home health care.
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